Literature DB >> 10733667

Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia.

C Mork1, C L Asker, E G Salerud, K Kvernebo.   

Abstract

Erythromelalgia is a condition consisting of red, warm, and burning painful extremities. Symptoms are relieved by cold and aggravated by heat. A wide variety of etiologic conditions can cause erythromelalgia, but one common pathogenetic mechanism, microvascular arteriovenous shunting, has been hypothesized. The aim of this study was to test this hypothesis. Quantification of skin microvascular perfusion using laser Doppler perfusion imaging and skin temperature at rest and after central body heating was performed in 14 patients with erythromelalgia and 11 controls. Attacks of erythromelalgia were induced in eight patients after heat provocation. In the plantar region of the foot, the location of numerous anatomical arteriovenous shunts, these patients significantly increased the skin perfusion as compared with asymptomatic patients with erythromelalgia and controls. In the dorsal region with few arteriovenous shunts no significant differences between the groups were demonstrated. The results show a relation between clinical symptoms and increased perfusion in the region of numerous anatomical arteriovenous shunts, and support the hypothesis of increased thermoregulatory arteriovenous shunt flow during attacks in primary erythromelalgia.

Entities:  

Mesh:

Year:  2000        PMID: 10733667     DOI: 10.1046/j.1523-1747.2000.00944.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

1.  Secondary erythromelalgia successfully treated with patient-controlled epidural analgesia and interferon α-2b: A case report and review of the literature.

Authors:  Xingzhi Li; Yaomin Li; Yao Qu; Laijin Lu
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

2.  Erythromelalgia.

Authors:  Mark D. P. Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

Review 3.  Mutational consequences of aberrant ion channels in neurological disorders.

Authors:  Dhiraj Kumar; Rashmi K Ambasta; Pravir Kumar
Journal:  J Membr Biol       Date:  2014-08-14       Impact factor: 1.843

4.  The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.

Authors:  J P Drenth; W H Finley; G J Breedveld; L Testers; J J Michiels; G Guillet; A Taieb; R L Kirby; P Heutink
Journal:  Am J Hum Genet       Date:  2001-03-20       Impact factor: 11.025

5.  Erythromelalgia.

Authors:  Mark D P Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

6.  Rheumatic diseases and malignancies.

Authors:  Violeta Bojinca; Iustina Janta
Journal:  Maedica (Buchar)       Date:  2012-12

7.  Late-onset erythromelalgia in a previously healthy young woman: a case report and review of the literature.

Authors:  Shobhana Gaur; Thomas Koroscil
Journal:  J Med Case Rep       Date:  2009-11-04

8.  Validation of Perfusion Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using a Blood Pool Contrast Agent in Skeletal Swine Muscle.

Authors:  Stefan Hindel; Anika Sauerbrey; Marc Maaß; Stefan Maderwald; Marc Schlamann; Lutz Lüdemann
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

9.  Erythromelalgia: an uncommon presentation precipitated by aspirin withdrawal.

Authors:  Fatima Khalid; Syed Hassan; Sophia Qureshi; Waqas Qureshi; Syed Amer
Journal:  Case Rep Med       Date:  2012-07-16

10.  Sodium channel Nav1.7 in vascular myocytes, endothelium, and innervating axons in human skin.

Authors:  Frank L Rice; Phillip J Albrecht; James P Wymer; Joel A Black; Ingemar Sj Merkies; Catharina G Faber; Stephen G Waxman
Journal:  Mol Pain       Date:  2015-05-09       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.